ImmunologybioRxiv
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines
X. Shen, H. Tang, C. McDana…·D. Montefiori
This study shows that B.1.1.7 SARS-CoV-2 variant remains neutralizable by antibodies from ancestral Spike vaccines and convalescent sera, though with reduced efficacy.
DOI 10.1016/j.chom.2021.03.002